Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01464346 · ClinicalTrials.gov registry record · NA
A Performance Evaluation of the Enlite Glucose Sensor to Support a Full 144 Hours(6Days) of Use
A NA study, sponsored by Medtronic MiniMed.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT01464346: Completed NA study, sponsored by Medtronic MiniMed.
NCT01464346 is a NA study that has completed, run by Medtronic MiniMed. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01464346, a NA study, has completed, sponsored by Medtronic MiniMed.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate the performance of the Enlite Sensor over an entire calibration and wear period of 146 hours (6 days) when inserted in the abdomen and buttock and used with the Revel 2.0 Pumps in subjects age 18 - 75 years.
Interventions
- DEVICE Enlite Sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2011-11 |
| Est. Completion | 2012-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01464346
The ClinicalTrials.gov registry entry for NCT01464346 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic MiniMed, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Enlite Sensor is the first listed.
NCT01464346 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01464346 about?
NCT01464346 is a clinical study titled "A Performance Evaluation of the Enlite Glucose Sensor to Support a Full 144 Hours(6Days) of Use". The purpose of this study is to demonstrate the performance of the Enlite Sensor over an entire calibration and wear period of 146 hours (6 days) when inserted in the abdomen and buttock and used with the Revel 2.0 Pumps in subjects age 18 - 75 years.
What is the current status of trial NCT01464346?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2011-11. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01464346?
The interventions under investigation include: Enlite Sensor (DEVICE).
Who is sponsoring clinical trial NCT01464346?
This trial is sponsored by Medtronic MiniMed, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.